Analgesic and antiinflammatory activity of constituents ofCannabis sativa L.

E. Formukong1, A.T. Evans2, Fred J. Evans2
1Department of Pharmacognosy, School of Pharmacy, University of London, England.
2Department of Pharmacognosy, The School of Pharmacy, University of London, London, (England)

Tóm tắt

Từ khóa


Tài liệu tham khảo

Pars, H. G., R. J.Razdan, and J. F.Howes. 1977. Potential therapeutic agents derived from the cannabinoid nucleus.Adv. Drug Res. 11.

O. L. Davies, J. Raventos, andA. L. Walpole. 1946. A method for evaluation of analgesic activity using rats.Br. J. Pharmacol. 1:255?264.

Gill, E. W., W. D. M. Paton, andR. G. Pertwee. 1970. Preliminary experiments on the chemistry and pharmacology ofCannabis.Nature 228:134?136.

Dewey, W. L., L. S. Harris, andJ. S. Kennedy. 1972. Some pharmacological and toxico-logical effects of 1-trans-?8-and 1-trans-?9-THC in laboratory rodents.Arch. Int. Pharmacodyn. 196:133?145.

Chesher, G. B., C. J. Dahl, M. Everinoham, D. M. Jackson, H. Marchant-Williams, andG. A. Starmer. 1973. The effect of cannabinoids on intestinal mobility and their antinociceptive effect in mice.Br.J. Pharmacol. 49:588?594.

Buxbaum, D., E. Sanders-Bush, andD. H. Efron. 1969. Analgesic activity of tetrahydro-cannabinol in the rat and mouse.Fed. Proc. 28:735.

Sanders, J., D. M. Jackson, andG. A. Starmer. 1979. Interactions among the cannabinoids in the antagonism of abdominal constriction response in the mouse.Psychopharmacology 61:281?285.

White, H. L., andR. L. Tansik. 1980. Effects of ?9-THC and cannabidiol on phospholipase and other enzymes regulating aracidonate metabolism.Prostaglandins Med. 4:409?411.

Burstein, S., andS. A. Hunter. 1978. Prostaglandins andCannabis VI. Release of arachidonic acid from HeLa cells by ?1-THC and other cannabinoids.Biochem. Pharmacol. 27:1275?1280.

Burstein, S. andA. Raz. 1972. Inhibition of prostaglandin E2 biosynthesis by ?1-tetrahydro-cannabinol.Prostaglandins 2:369.

Burstein, S., E. Levine, andC. Varanelli. 1973. Prostaglandins andCannabis II. Inhibition of biosynthesis by the naturally occurring cannabinoids.Biochem. Pharmacol. 22:2905?2910.

Barrett, M. L., D. Gordon, andF. J. Evans. 1985. Isolation fromCannabis sativa L of cannflavin: A novel inhibitor of prostaglandin production.Biochem. Pharmacol. 34:2019?2024.

Evans, A. T., E. A. Formukong, andF. J. Evans. 1987. Activation of phospholipase A2 by cannabinoids. Lack of correlation with CNS effects.FEBS Lett. 211:119?122.

Evans, A. T., E. A. Formukong, F. J. Evans. 1987. Actions ofCannabis constitutents on enzymes of prostaglandin synthesis: Antiinfiammatory potential.Biochem. Pharmacol. 36:2035?2037.

Parkes, M. W., andJ. T. Pickens. 1965. Conditions influencing the inhibition of analgesic drugs of the response to intraperitoneal injections of phenylbenzoquine in mice.Br. J. Pharmacol. 25:81?87.

Siegmund, E. A., R. A. Cadmus, andG. Lu. 1957. A method for evaluating both nonnarcotic and narcotic analgesics.Proc. Soc. Exp. Biol. 95:729?731.

Hendershot, L. C., andJ. Forsaith. 1959. Antagonism of the frequency of phenylbenzoquinone induced writhing in the mouse by weak analgesics and nonanalgesics.J. Pharmacol. Exp. Ther. 125:237?240.

Kinghorn, A. D., andF. J. Evans. 1975. A biological screen of selected species of the genusEuphorbia for skin irritant effects.Planta Med. 28:325.

Williamson, E. M., andF. J. Evans. 1981. Inhibition of erythema induced by proinflammatory esters of 12-deoxyphorbol.Acta Pharmacol. Toxicol. 481:47?52.

Williamson, E. M., J. Westwick, V. V. Kakkar, andF. J. Evans. 1981. Studies on the mechanism of action of 12-DOPP, a potent platelet aggregating phorbol ester.Biochem. Pharmacol. 30:2691?2696.

Collier, H. O. J., L. C. Dineen, C. A. Johnson, andC. Schneider. 1968. Abdominal constriction response and its suppression by analgesic drugs in the mouse.Br. J. Pharmacol. Chemother. 32:295?310.

Marks, P., G. Furstenberger, andE. Kownatzki. 1981. Prostaglandin E-mediated mitogenic stimulation of mouse epidermis in vivo by divalent cation ionophore A23187 and by tumor promoter 12-O-tetradecanoyl phorbol-13-acetate.Cancer Res. 41:696?702.

Humes, J. L., S. Sadowski, M. Galavage, M. Goldenberg, E. Subers, R. J. Bonney, andF. A. Kuehl. 1982. Evidence for two sources of arachidonic acid for oxidative metabolism by mouse peritoneal macrophages.J. Biol. Chem. 257:1291?1594.

Edwards, M. C., andF. J. Evans. 1987. Activity correlations in the phorbol ester series.Bot. J. Linn. Soc. 94:231?246.

Calson, R. P., L. O'neill-David, J. Chary, andA. J. Lewis. 1985. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmaoclogical agents.Agents Actions 17:197?204.

Formukong, E. A., A. T.Evans, F. J.Evans. 1987. Inhibition of the cataleptic effect of ?1-tetrahydrocannabinol by noncateleptic constituents ofCannabis sativa L.J. Pharm. Pharmacol. (in press).